FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Sotomayor denies mom’s bid to get son into elite NYC school amid racial discrimination fight

FAA breaks controller hiring record after chief warned system was ‘chronically understaffed’

Biden-era federal prosecutor hit with criminal investigation referral over alleged false statements to FBI

States leading nation on the biggest education battles gripping classrooms revealed in first-ever report

Bipartisan data center bill fractures Democrats ahead of midterm elections

1 missing, 4 rushed to hospital after helicopter crashes off Southern California island

Arizona sheriff’s helicopter crew rescues man stranded atop overturned truck in rapidly rising floodwaters

TikTok couple charged with arson after house fire causes $10K in damage

NBA Champion New York Knicks Still Deciding Whether to Visit Trump White House

Suspect arrested after alleged plot to attack Texas Capitol: officials

Watch: WNBA MVP Loses Her Cool While Getting Crushed by Caitlin Clark, Goes Into Stands to Confront Fan

San Francisco Burglar Picks the Wrong House, Takes a Bullet in the Backside from Vietnam Vet

Supreme Court Stiff-Arms Biden-Appointed Judge, Allows Trump Admin to Resume Third-Country Deportations

ICE arrests illegal alien accused of sexually assaulting children after Fairfax County release: DHS

Trump Sending Out Checks to Nearly 1 Million Americans – Here’s Why

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”